Use, perceptions, and effectiveness of e-cigarettes for smoking cessation among older adults in England: a population study, 2014-2024.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
31 Oct 2024
Historique:
received: 14 06 2024
accepted: 25 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

This study aimed to characterise patterns of tobacco smoking and vaping among older adults (≥ 65 years) in England, to explore harm perceptions of e-cigarettes among those who smoke, and to estimate the real-world effectiveness of e-cigarettes for helping older adults to stop smoking. Data were collected as part of a representative monthly cross-sectional household survey in England between April 2014 and April 2024 (n = 197,219). We analysed differences between older (≥ 65 years) and younger/middle-aged adults (18-64 years) in (a) time trends in tobacco smoking and vaping, (b) harm perceptions of e-cigarettes vs. cigarettes (adjusting for gender, socioeconomic position, and vaping status), and (c) the real-world effectiveness of e-cigarettes for smoking cessation (adjusting for gender, socioeconomic position, characteristics of the quit attempt, and use of other evidence-based cessation aids). Tobacco smoking prevalence remained relatively unchanged over time among older adults (at ~ 9%; 9.5% [8.5-10.6%] in April 2014 and 8.7% [7.7-9.8%] in April 2024) but vaping prevalence increased (from 2.1% [1.6-2.7%] to 3.7% [3.0-4.6%], respectively). These trends differed from those observed among younger/middle-aged adults, among whom there was a clear decline in smoking (from 21.8% [21.0-22.7%] to 18.2% [17.3-19.0%]) and a larger increase in vaping (from 5.6% [5.2-6.1%] to 16.2% [15.3-17.0%]). Older adults were consistently less likely than younger/middle-aged adults to use e-cigarettes to support attempts to quit smoking (26.8% [17.2-39.3%] vs. 43.7% [39.6-48.0%] in April 2024). Older smokers reported greater uncertainty about the harms of e-cigarettes compared with cigarettes (OR Over the past decade, smoking prevalence has remained stable among older adults while decreasing among the rest of the adult population in England. Older adults are more unsure about the relative harms of e-cigarettes and less likely to use them to support attempts to quit smoking, despite evidence that they are effective for smoking cessation in this population.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to characterise patterns of tobacco smoking and vaping among older adults (≥ 65 years) in England, to explore harm perceptions of e-cigarettes among those who smoke, and to estimate the real-world effectiveness of e-cigarettes for helping older adults to stop smoking.
METHODS METHODS
Data were collected as part of a representative monthly cross-sectional household survey in England between April 2014 and April 2024 (n = 197,219). We analysed differences between older (≥ 65 years) and younger/middle-aged adults (18-64 years) in (a) time trends in tobacco smoking and vaping, (b) harm perceptions of e-cigarettes vs. cigarettes (adjusting for gender, socioeconomic position, and vaping status), and (c) the real-world effectiveness of e-cigarettes for smoking cessation (adjusting for gender, socioeconomic position, characteristics of the quit attempt, and use of other evidence-based cessation aids).
RESULTS RESULTS
Tobacco smoking prevalence remained relatively unchanged over time among older adults (at ~ 9%; 9.5% [8.5-10.6%] in April 2014 and 8.7% [7.7-9.8%] in April 2024) but vaping prevalence increased (from 2.1% [1.6-2.7%] to 3.7% [3.0-4.6%], respectively). These trends differed from those observed among younger/middle-aged adults, among whom there was a clear decline in smoking (from 21.8% [21.0-22.7%] to 18.2% [17.3-19.0%]) and a larger increase in vaping (from 5.6% [5.2-6.1%] to 16.2% [15.3-17.0%]). Older adults were consistently less likely than younger/middle-aged adults to use e-cigarettes to support attempts to quit smoking (26.8% [17.2-39.3%] vs. 43.7% [39.6-48.0%] in April 2024). Older smokers reported greater uncertainty about the harms of e-cigarettes compared with cigarettes (OR
CONCLUSIONS CONCLUSIONS
Over the past decade, smoking prevalence has remained stable among older adults while decreasing among the rest of the adult population in England. Older adults are more unsure about the relative harms of e-cigarettes and less likely to use them to support attempts to quit smoking, despite evidence that they are effective for smoking cessation in this population.

Identifiants

pubmed: 39482655
doi: 10.1186/s12916-024-03728-x
pii: 10.1186/s12916-024-03728-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

500

Subventions

Organisme : Cancer Research UK
ID : PRCRPG-Nov21\100002
Pays : United Kingdom
Organisme : Cancer Research UK
ID : PRCRPG-Nov21\100002
Pays : United Kingdom
Organisme : Cancer Research UK
ID : PRCRPG-Nov21\100002
Pays : United Kingdom
Organisme : Cancer Research UK
ID : PRCRPG-Nov21\100002
Pays : United Kingdom

Informations de copyright

© 2024. The Author(s).

Références

Park E, Kang H-Y, Lim MK, Kim B, Oh J-K. Cancer Risk Following Smoking Cessation in Korea. JAMA Netw Open. 2024;7:e2354958.
doi: 10.1001/jamanetworkopen.2023.54958 pubmed: 38319658
Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328:1519.
doi: 10.1136/bmj.38142.554479.AE pubmed: 15213107
Taylor DH, Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of Smoking Cessation for Longevity. Am J Public Health. 2002;92:990–6.
doi: 10.2105/AJPH.92.6.990 pubmed: 12036794
Timmermans EJ, Huisman M, Kok AAL, Kunst AE. Smoking Cessation and 16-year Trajectories of Functional Limitations Among Dutch Older Adults: Results from the Longitudinal Aging Study Amsterdam. J Gerontol A Biol Sci Med Sci. 2018;73:1722–8.
doi: 10.1093/gerona/gly009 pubmed: 29462269
Le TTT, Mendez D, Warner KE. The benefits of quitting smoking at different ages. Am J Prev Med. 2024;67(5):684–8.
U.S. Department of health and human services. The health consequences of smoking—50 years of progress: a report of the surgeon general. Atlanta, GA: U.S. Department of health and human services, centers for disease control and prevention, national center for chronic disease prevention and health promotion, office on smoking and health; 2014.
Cancer Research UK. Cancer incidence by age. Cancer Research UK. 2015. https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/age . Accessed 16 Feb 2024.
Office for National Statistics. Adult smoking habits in the UK: 2022. 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/adultsmokinghabitsingreatbritain/2022 . Accessed 2 May 2024.
Office for National Statistics. Population estimates for the UK, England, Wales, Scotland, and Northern Ireland: mid-2022. 2024. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulationestimates/mid2022 . Accessed 2 May 2024.
Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024. https://doi.org/10.1002/14651858.CD010216.pub8 .
doi: 10.1002/14651858.CD010216.pub8 pubmed: 38189560
Auer R, Schoeni A, Humair J-P, Jacot-Sadowski I, Berlin I, Stuber MJ, et al. Electronic Nicotine-Delivery Systems for Smoking Cessation. N Engl J Med. 2024;390:601–10.
doi: 10.1056/NEJMoa2308815 pubmed: 38354139
McNeill A, Simonavicius E, Brose LS, Taylor E, East K, Zuikova E, et al. Nicotine vaping in England: an evidence update including health risks and perceptions, September 2022. A report commissioned by the office for health improvement and disparities. London: Office for Health Improvement and Disparities; 2022. https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update . Accessed 4 May 2024.
Jackson SE, Kotz D, West R, Brown J. Moderators of real-world effectiveness of smoking cessation aids: a population study. Addiction. 2019;114:1627–38.
doi: 10.1111/add.14656 pubmed: 31117151
Meza R, Cao P, Jeon J, Warner KE, Levy DT. Trends in US Adult Smoking Prevalence, 2011 to 2022. JAMA Health Forum. 2023;4:e234213.
doi: 10.1001/jamahealthforum.2023.4213 pubmed: 38038988
Jackson SE, Shahab L, Brown J. Trends in exclusive non-cigarette tobacco smoking in England: a population survey 2013–2023. Nicotine Tob Res. 2024;ntae021. https://doi.org/10.1093/ntr/ntae021 .
Buss V, West R, Kock L, Kale D, Brown J. Top-line findings on smoking in England from the Smoking Toolkit Study. 2024. https://smokinginengland.info/graphs/top-line-findings . Accessed 7 Aug 2024.
Buss V, Kock L, West R, Kale D, Brown J. Trends in electronic cigarette use in England. 2024. https://smokinginengland.info/graphs/e-cigarettes-latest-trends . Accessed 4 May 2024.
Jackson SE, Tattan-Birch H, Shahab L, Brown J. Trends in long term vaping among adults in England, 2013–23: population based study. BMJ. 2024;386:e079016.
doi: 10.1136/bmj-2023-079016 pubmed: 39019543
Jackson SE, Tattan-Birch H, East K, Cox S, Shahab L, Brown J. Trends in Harm Perceptions of E-Cigarettes vs Cigarettes Among Adults Who Smoke in England, 2014–2023. JAMA Netw Open. 2024;7:e240582.
doi: 10.1001/jamanetworkopen.2024.0582 pubmed: 38416490
Lindson N, Theodoulou A, Ordóñez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J, et al. Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses. Cochrane Database Syst Rev. 2023. https://doi.org/10.1002/14651858.CD015226.pub2 .
doi: 10.1002/14651858.CD015226.pub2 pubmed: 37696529
Jackson SE, Brown J, Beard E. Associations of prevalence of e-cigarette use with quit attempts, quit success, use of smoking cessation medication, and the overall quit rate among smokers in England: A time-series analysis of population trends 2007–2022. Nicotine Tob Res. 2024;26(7):826–324.
Fidler JA, Shahab L, West O, Jarvis MJ, McEwen A, Stapleton JA, et al. “The smoking toolkit study”: a national study of smoking and smoking cessation in England. BMC Public Health. 2011;11:479.
doi: 10.1186/1471-2458-11-479 pubmed: 21682915
Kock L, Shahab L, Moore G, Beard E, Bauld L, Reid G, et al. Protocol for expansion of an existing national monthly survey of smoking behaviour and alcohol use in England to Scotland and Wales: The Smoking and Alcohol Toolkit Study. Wellcome Open Res. 2021;6:67.
doi: 10.12688/wellcomeopenres.16700.1 pubmed: 34458587
Kock L, Tattan-Birch H, Jackson S, Shahab L, Brown J. Socio-demographic, smoking and drinking characteristics in GB: A comparison of independent telephone and face-to-face Smoking and Alcohol Toolkit surveys conducted in March 2022. Qeios. 2022. https://doi.org/10.32388/CLXK4D .
Office for National Statistics. Profile of the older population living in England and Wales in 2021 and changes since 2011. 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/articles/profileoftheolderpopulationlivinginenglandandwalesin2021andchangessince2011/2023-04-03 . Accessed 15 Feb 2024.
National Readership Survey. Social Grade. http://www.nrs.co.uk/nrs-print/lifestyle-and-classification-data/social-grade/ . Accessed 4 May 2024.
Kotz D, West R. Explaining the social gradient in smoking cessation: it’s not in the trying, but in the succeeding. Tob Control. 2009;18:43–6.
doi: 10.1136/tc.2008.025981 pubmed: 18936053
Jackson SE, Cox S, Shahab L, Brown J. Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England. Addiction. 2022;117:2504–14.
doi: 10.1111/add.15903 pubmed: 35491743
Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addict Abingdon Engl. 2011;106:631–8.
doi: 10.1111/j.1360-0443.2010.03226.x
Tattan-Birch H. BayesFactor.info. https://harry-tattan-birch.shinyapps.io/bayes-factor-calculator/ . Accessed 4 May 2024.
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD001292.pub3 .
doi: 10.1002/14651858.CD001292.pub3 pubmed: 28361497
Dienes Z. Using Bayes to get the most out of non-significant results. Front Psychol. 2014;5:781.
doi: 10.3389/fpsyg.2014.00781 pubmed: 25120503
Jeffreys H. The theory of probability. Oxford: Oxford University Press; 1998.
Action on smoking and health. Use of e-cigarettes among adults in Great Britain. 2022.
Majeed BA, Weaver SR, Gregory KR, Whitney CF, Slovic P, Pechacek TF, et al. Changing Perceptions of Harm of E-Cigarettes Among US Adults, 2012–2015. Am J Prev Med. 2017;52:331–8.
doi: 10.1016/j.amepre.2016.08.039 pubmed: 28341303
Wilson S, Partos T, McNeill A, Brose LS. Harm perceptions of e-cigarettes and other nicotine products in a UK sample. Addict Abingdon Engl. 2019. https://doi.org/10.1111/add.14502 .
doi: 10.1111/add.14502
Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109:1531–40.
doi: 10.1111/add.12623 pubmed: 24846453
Beard E, West R, Michie S, Brown J. Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends. BMJ. 2016;354:i4645.
doi: 10.1136/bmj.i4645 pubmed: 27624188
Beard E, West R, Michie S, Brown J. Association of prevalence of electronic cigarette use with smoking cessation and cigarette consumption in England: a time–series analysis between 2006 and 2017. Addiction. 2020;115:961–74.
doi: 10.1111/add.14851 pubmed: 31621131
Yong H-H, Hitchman SC, Cummings KM, Borland R, Gravely SML, McNeill A, et al. Does the Regulatory Environment for E-Cigarettes Influence the Effectiveness of E-Cigarettes for Smoking Cessation?: Longitudinal Findings From the ITC Four Country Survey. Nicotine Tob Res. 2017;19:1268–76.
doi: 10.1093/ntr/ntx056 pubmed: 28340053
Kock L, Shahab L, West R, Brown J. E-cigarette use in England 2014–17 as a function of socio-economic profile. Addict Abingdon Engl. 2018. https://doi.org/10.1111/add.14446 .
doi: 10.1111/add.14446
Tattan-Birch H, Brown J, Shahab L, Beard E, Jackson SE. Trends in vaping and smoking following the rise of disposable e-cigarettes: a repeat cross-sectional study in England between 2016 and 2023. Lancet Reg Health - Eur. 2024;42:100924.
doi: 10.1016/j.lanepe.2024.100924 pubmed: 39070753
Jackson SE, Shahab L, Tattan-Birch H, Brown J. Vaping among adults in England who have never regularly smoked: a population-based study, 2016–24. Lancet Public Health. 2024;9(10):E755–65.

Auteurs

Sarah E Jackson (SE)

Department of Behavioural Science and Health, University College London, 1-19, London, Torrington Place, WC1E 7HB, UK. s.e.jackson@ucl.ac.uk.
SPECTRUM Consortium, Edinburgh, UK. s.e.jackson@ucl.ac.uk.

Jamie Brown (J)

Department of Behavioural Science and Health, University College London, 1-19, London, Torrington Place, WC1E 7HB, UK.
SPECTRUM Consortium, Edinburgh, UK.

Lion Shahab (L)

Department of Behavioural Science and Health, University College London, 1-19, London, Torrington Place, WC1E 7HB, UK.
SPECTRUM Consortium, Edinburgh, UK.

Sharon Cox (S)

Department of Behavioural Science and Health, University College London, 1-19, London, Torrington Place, WC1E 7HB, UK.
SPECTRUM Consortium, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH